Director, Global Oncology Pricing, Reimbursement & Access
Join a Legacy of Innovation 110 Years and Counting!
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.
The Director Pricing, Reimbursement & Access will lead the development of global pricing, reimbursement and access strategies for the Daiichi Sankyo early-stage oncology assets, including both solid tumor & hematology assets and will be working cross-functionally with global, regional and country teams, including Pricing, Reimbursement and Access (PRA), Clinical development, HEOR, Forecasting, Pricing Analytics, Marketing and Medical Affairs.
He/she will be working with the New Product Planning team and provide the PRA assumptions for forecasting, in close collaboration with regions and key countries. He/she will partner with RD to ensure requirements for successful market access are factored in the early development plans.
- Global Market Access & Strategy
- Lead the development of pricing, reimbursement and access strategies working cross-functionally/regionally
- Develop initial price assumptions and reimbursement & access strategy recommendations
- Draft and establish price guidance in collaboration with top countries and regions, including design of a global launch
sequence plan by collaborating cross-functionally
- Provide pricing input to key planning processes for Brand planning and portfolio review
- Provides input to Clinical on trial design, endpoints and comparators to support optimal price, access and reimbursement
- Enhance information exchange and best practice sharing across regions; drive adoption of pricing tools and resources
- Ensure pricing inputs & assumptions are incorporated into the forecasting and strategic planning process
- Monitor fast-changing competitive landscape and ensure insights factored in the PRA strategy
- Evidence Generation & Synthesis
- Collaborate cross-functionally to gather overview information of target indications including epidemiology, disease burden, unmet needs, cost of illness, and treatment patterns/pathways
- Provide and maintain an in-depth understanding of changing pricing, reimbursement & access environment, processes, and policies of key global markets
- Conduct pricing &payer market research in collaboration with key markets/regions
- Stakeholder Engagement
- Partner with Regional and Global stakeholders to provide innovative PRA approaches
- Collaborate with Clinical (R&D) to ensure that Payer and KOL reimbursement requirements for key markets are included in the clinical trial / evidence generation plans
- Act as an ambassador to drive the access agenda with key stakeholders
Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.
Education Qualifications (from an accredited college or university)
- Master's Degree in economics, health policy, health economics, pharmaceutical sciences, medicines, or other relevant qualification required
- 7 or More Years of progressive relevant experience acquired at pharmaceutical companies, Payer/HTA, physician associations or relevant consultancy companies in a multi-national context: cross- country experience or commensurate experience
- Demonstrated experience with developing global pricing, reimbursement and access strategies
- Having worked in oncology, preferably with multi-indication compounds as well as with early-stage compounds
- Excellent understanding of the clinical development and life cycle of oncology medicines
- Experience in collaboration with early assets teams, clinical development and forecasting teams
- Strong knowledge of major markets and their PRA and HTA policies: US and Global (at minimum, Europe), both private and government setting
- Knowledge of pricing and reimbursement schemes in different areas of the world
- Excellent knowledge of pricing market research tools, methodologies, and analytics
- Good understanding of HEOR and RWE concepts required
Ability to travel up to 30% (Domestic and international travel)
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.